部位 | ICD-O-3 | 合計 | 男性 | 女性 | |||
---|---|---|---|---|---|---|---|
件数 | % | 件数 | % | 件数 | % | ||
全部位 | 3,105 | 100.0% | 1,707 | 100.0% | 1,398 | 100.0% | |
頭頸部 | C00-C14 C30-C32 | 171 | 5.5% | 121 | 7.1% | 50 | 3.6% |
食道 | C15 | 193 | 6.2% | 168 | 9.8% | 25 | 1.8% |
胃 | C16 | 238 | 7.7% | 167 | 9.8% | 71 | 5.1% |
大腸 | C18-C21 | 199 | 6.4% | 116 | 6.8% | 83 | 5.9% |
(結腸) | C18 | 104 | 3.3% | 54 | 3.2% | 50 | 3.6% |
(直腸S状結腸移行部、直腸、肛門及び肛門管) | C19-C21 | 95 | 3.1% | 62 | 3.6% | 33 | 2.4% |
肝及び肝内胆管 | C22 | 101 | 3.3% | 68 | 4.0% | 33 | 2.4% |
膵 | C25 | 100 | 3.2% | 58 | 3.4% | 42 | 3.0% |
気管、気管支及び肺 | C33-C34 | 239 | 7.7% | 166 | 9.7% | 73 | 5.2% |
血管、骨髄 | C420 C421 | 105 | 3.4% | 59 | 3.5% | 46 | 3.3% |
乳房 | C50 | 309 | 10.0% | 0 | 0.0% | 309 | 22.1% |
子宮 | C53-C54 | 194 | 6.2% | - | - | 194 | 13.9% |
(子宮頚) | C53 | 110 | 3.5% | - | - | 110 | 7.9% |
(子宮体部) | C54 | 84 | 2.7% | - | - | 84 | 6.0% |
前立腺 | C61 | 249 | 8.0% | 249 | 14.6% | - | - |
髄膜、脳、脊髄、脳神経及びその他の中枢神経系 | C70-C72 | 182 | 5.9% | 102 | 6.0% | 80 | 5.7% |
悪性リンパ腫 | M959-M972 | 160 | 5.2% | 82 | 4.8% | 78 | 5.6% |
その他(100件未満) | 665 | 21.4% | 351 | 20.6% | 314 | 22.5% |
※4 登録症例が年間100例に満たないものはその他に含みます。
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 96.4% | 100.0% | 80.0% | 18.5% | 100.0% | 0.0% | 84.4% |
手術 | 41.4% | 100.0% | 80.0% | 18.5% | 20.0% | 0.0% | 39.4% |
(うち、体腔鏡的治療) | 25.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 19.4% |
内視鏡的治療 | 60.7% | 0.0% | 0.0% | 0.0% | 80.0% | 0.0% | 49.4% |
放射線療法 | 0.0% | 0.0% | 0.0% | 7.4% | 0.0% | 0.0% | 1.1% |
化学療法 | 2.9% | 100.0% | 40.0% | 81.5% | 0.0% | 0.0% | 17.2% |
レーザー等治療 | 1.4% | 0.0% | 0.0% | 0.0% | 20.0% | 0.0% | 1.7% |
その他 | 0.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.6% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 100.0% | 96.6% | 92.9% | 90.9% | 76.9% | 50.0% | 100.0% | 90.4% |
手術 | 40.0% | 96.6% | 92.9% | 90.9% | 76.9% | 25.0% | 100.0% | 83.0% |
(うち、体腔鏡的治療) | 20.0% | 20.7% | 21.4% | 13.6% | 7.7% | 0.0% | 0.0% | 16.0% |
内視鏡的治療 | 80.0% | 3.4% | 0.0% | 0.0% | 0.0% | 25.0% | 0.0% | 10.6% |
放射線療法 | 0.0% | 0.0% | 0.0% | 4.5% | 7.7% | 0.0% | 0.0% | 2.1% |
化学療法 | 0.0% | 0.0% | 14.3% | 18.2% | 69.2% | 25.0% | 50.0% | 18.1% |
レーザー等治療 | 10.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.1% |
その他 | 0.0% | 0.0% | 0.0% | 4.5% | 0.0% | 0.0% | 0.0% | 1.1% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 46.2% | 52.2% | 47.1% | 50.0% | 0.0% | 0.0% | 48.6% |
手術 | 46.2% | 52.2% | 47.1% | 50.0% | 0.0% | 0.0% | 48.6% |
放射線療法 | 0.0% | 8.7% | 17.6% | 0.0% | 0.0% | 0.0% | 6.9% |
化学療法 | 11.5% | 21.7% | 41.2% | 33.3% | 0.0% | 0.0% | 23.6% |
TAE | 34.6% | 43.5% | 23.5% | 0.0% | 0.0% | 0.0% | 31.9% |
レーザー等治療 | 42.3% | 17.4% | 5.9% | 0.0% | 0.0% | 0.0% | 22.2% |
その他 | 3.8% | 4.3% | 5.9% | 16.7% | 0.0% | 0.0% | 5.6% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 78.5% | 66.7% | 14.3% | 3.6% | 100.0% | 100.0% | 40.6% |
手術 | 76.9% | 66.7% | 14.3% | 3.6% | 100.0% | 100.0% | 40.1% |
(うち、体腔鏡的治療) | 66.2% | 13.3% | 4.1% | 0.0% | 71.4% | 0.0% | 27.1% |
内視鏡的治療 | 1.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.5% |
放射線療法 | 21.5% | 20.0% | 46.9% | 41.8% | 14.3% | 0.0% | 33.3% |
化学療法 | 20.0% | 46.7% | 77.6% | 85.5% | 14.3% | 0.0% | 55.2% |
その他 | 0.0% | 0.0% | 2.0% | 1.8% | 0.0% | 0.0% | 1.0% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術の割合 | 100.0% | 96.4% | 92.3% | 77.8% | 12.5% | 100.0% | 0.0% | 88.6% |
放射線療法 | 28.6% | 34.5% | 42.3% | 44.4% | 12.5% | 50.0% | 0.0% | 35.1% |
化学療法 | 7.1% | 29.1% | 80.8% | 77.8% | 100.0% | 0.0% | 0.0% | 46.5% |
内分泌療法 | 57.1% | 65.5% | 19.2% | 0.0% | 0.0% | 50.0% | 0.0% | 43.9% |
(重複あり)